Evidence map›Paper›PMID 35414105›Full record

ArticleMolecular neurodegeneration2022

VCP suppresses proteopathic seeding in neurons.

Jiang Zhu, Sara Pittman, Dhruva Dhavale, Rachel French, Jessica N Patterson, Mohamed Salman Kaleelurrrahuman, Yuanzi Sun, Jaime Vaquer-Alicea, Gianna Maggiore, Christoph S Clemen and 7 more

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. In-vivo evidence of synucleinopathy in parkinsonism due to VCP mutation.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Jiang ZhuDepartment of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, MO, 63110, USA.
Sara PittmanDepartment of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, MO, 63110, USA.
Dhruva DhavaleDepartment of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, MO, 63110, USA.
Rachel FrenchEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, USA.
Jessica N PattersonDepartment of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, MO, 63110, USA.
Mohamed Salman KaleelurrrahumanDepartment of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, MO, 63110, USA.
Yuanzi SunMedical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK.
Jaime Vaquer-AliceaCenter for Alzheimer's and Neurodegenerative Diseases, Peter O' Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Gianna MaggioreCenter for Alzheimer's and Neurodegenerative Diseases, Peter O' Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Christoph S ClemenInstitute of Aerospace Medicine, German Aerospace Center, Cologne, Germany.
William J BuscherDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
Jan BieschkeMedical Research Council Prion Unit / UCL Institute of Prion Diseases, University College London, London, UK.
Paul KotzbauerDepartment of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, MO, 63110, USA.
Yuna AyalaEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, USA.
Marc I DiamondCenter for Alzheimer's and Neurodegenerative Diseases, Peter O' Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Albert A DavisDepartment of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, MO, 63110, USA.
Conrad WeihlDepartment of Neurology, Hope Center for Neurological Diseases, Washington University School of Medicine, St Louis, MO, 63110, USA. weihlc@wustl.edu.ORCID 0000-0002-3816-6124
Hope Center for Neurological Disorders · USThe University of Texas Southwestern Medical Center · USMRC Prion Unit · GBSaint Louis University · USUniversity of Cologne · DEWashington University in St. Louis · US

Funding

VCP in myopathy and dementiaR01AG031867 · NIA · WASHINGTON UNIVERSITY · PI CONRAD C WEIHL · 2009 to 2026
$9.1M
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIAU01NS110436 · NINDS · WASHINGTON UNIVERSITY · PI KOTZBAUER, PAUL T · 2018 to 2022
$4.1M
Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementiaR01NS114289 · NINDS · SAINT LOUIS UNIVERSITY · PI AYALA, YUNA · 2020 to 2024
$1.9M
Clinical and Translational Studies in Muscle DiseaseK24AR073317 · NIAMS · WASHINGTON UNIVERSITY · PI CONRAD C WEIHL · 2018 to 2026
$1.6M
ApoE Regulation of Alpha-Synuclein Pathology in Parkinson Disease DementiaK08NS101118 · NINDS · WASHINGTON UNIVERSITY · PI DAVIS, ALBERT A · 2017 to 2021
$859k
Medical Research Council MC_UU_00024/6NIAMS NIH HHS K24 AR073317NIA NIH HHS R01 AG031867NINDS NIH HHS K08 NS101118NINDS NIH HHS R01 NS114289NINDS NIH HHS U01 NS110436
6 · The paper itself

Abstract

backgroundNeuronal uptake and subsequent spread of proteopathic seeds, such as αS (alpha-synuclein), Tau, and TDP-43, contribute to neurodegeneration. The cellular machinery participating in this process is poorly understood. One proteinopathy called multisystem proteinopathy (MSP) is associated with dominant mutations in Valosin Containing Protein (VCP). MSP patients have muscle and neuronal degeneration characterized by aggregate pathology that can include αS, Tau and TDP-43.

methodsWe performed a fluorescent cell sorting based genome-wide CRISPR-Cas9 screen in αS biosensors. αS and TDP-43 seeding activity under varied conditions was assessed using FRET/Flow biosensor cells or immunofluorescence for phosphorylated αS or TDP-43 in primary cultured neurons. We analyzed in vivo seeding activity by immunostaining for phosphorylated αS following intrastriatal injection of αS seeds in control or VCP disease mutation carrying mice.

resultsOne hundred fifty-four genes were identified as suppressors of αS seeding. One suppressor, VCP when chemically or genetically inhibited increased αS seeding in cells and neurons. This was not due to an increase in αS uptake or αS protein levels. MSP-VCP mutation expression increased αS seeding in cells and neurons. Intrastriatal injection of αS preformed fibrils (PFF) into VCP-MSP mutation carrying mice increased phospho αS expression as compared to control mice. Cells stably expressing fluorescently tagged TDP-43 C-terminal fragment FRET pairs (TDP-43 biosensors) generate FRET when seeded with TDP-43 PFF but not monomeric TDP-43. VCP inhibition or MSP-VCP mutant expression increases TDP-43 seeding in TDP-43 biosensors. Similarly, treatment of neurons with TDP-43 PFFs generates high molecular weight insoluble phosphorylated TDP-43 after 5 days. This TDP-43 seed dependent increase in phosphorlyated TDP-43 is further augmented in MSP-VCP mutant expressing neurons.

conclusionUsing an unbiased screen, we identified the multifunctional AAA ATPase VCP as a suppressor of αS and TDP-43 aggregate seeding in cells and neurons. VCP facilitates the clearance of damaged lysosomes via lysophagy. We propose that VCP's surveillance of permeabilized endosomes may protect against the proteopathic spread of pathogenic protein aggregates. The spread of distinct aggregate species may dictate the pleiotropic phenotypes and pathologies in VCP associated MSP.

Indexed as

DNA-Binding ProteinsNeuronsAnimalsHumansMiceMutationValosin Containing ProteinDNA-Binding ProteinsValosin Containing ProteinVCP protein, humanAlpha-synucleinCRISPR screenFrontotemporal dementiaSeedingTDP-43

Identifiers

PMID35414105
PMCPMC9004082
OpenAlexW4223568508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.